We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
Cap. Flow
+$3.06B
Cap. Flow %
15.66%
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288

Sector Composition

Rank Sector Weight
1 Healthcare 22.23%
2 Technology 20.39%
3 Consumer Discretionary 13.52%
4 Financials 8.95%
5 Communication Services 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZLAB icon
1126
Zai Lab
ZLAB
$2.07B
-1,090
Closed -$90K
ZM icon
1127
Zoom
ZM
$29B
-4,893
Closed -$1.24M
ZS icon
1128
Zscaler
ZS
$24.9B
-14,352
Closed -$1.57M
ZTS icon
1129
Zoetis
ZTS
$32.6B
-163,800
Closed -$22.4M
QTTB icon
1130
Q32 Bio
QTTB
$459M
-8,226
Closed -$2.25M
CNH
1131
CNH Industrial
CNH
$14.1B
-45,730
Closed -$280K
CMRX
1132
DELISTED
Chimerix, Inc.
CMRX
-625,929
Closed -$1.94M
GTHX
1133
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
-104,157
Closed -$2.53M
SPWR
1134
DELISTED
SunPower Corporation Common Stock
SPWR
-1,278,753
Closed -$6.42M
ETRN
1135
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-2,703,586
Closed -$22.5M
FUSN
1136
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-60,000
Closed -$1.05M
CBAY
1137
DELISTED
Cymabay Therapeutics
CBAY
-576,638
Closed -$2.01M
AYX
1138
DELISTED
Alteryx Inc
AYX
-381,277
Closed -$62.6M
MRTX
1139
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-186,721
Closed -$21.3M
FTCH
1140
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-104,873
Closed -$1.81M
NEWR
1141
DELISTED
New Relic, Inc.
NEWR
-156,650
Closed -$10.8M
GTH
1142
DELISTED
Genetron Holdings Limited ADS
GTH
-21,667
Closed -$785K
SYNH
1143
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-707,612
Closed -$41.2M
RETA
1144
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-146,938
Closed -$22.9M
BLU
1145
DELISTED
BELLUS Health Inc.
BLU
-343,248
Closed -$3.53M
STSA
1146
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
-62,615
Closed -$1.8M
OBSV
1147
DELISTED
ObsEva SA Ordinary Shares
OBSV
-275,000
Closed -$1.62M
IAA
1148
DELISTED
IAA, Inc. Common Stock
IAA
-181,529
Closed -$7M
ALBO
1149
DELISTED
Albireo Pharma Inc
ALBO
-175,000
Closed -$4.64M
VLDR
1150
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-34,000
Closed -$473K

Similar funds

Point72 Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.

  • Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
  • Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
  • Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
  • Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
  • Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
  • Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
  • Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.

Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.